Connor M. Webb

ORCID: 0000-0003-2304-2310
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmacological Effects of Natural Compounds
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Parkinson's Disease Mechanisms and Treatments
  • Neurological diseases and metabolism
  • Antimicrobial Peptides and Activities
  • Melanoma and MAPK Pathways
  • Systemic Lupus Erythematosus Research
  • Chemokine receptors and signaling
  • Alzheimer's disease research and treatments
  • Mosquito-borne diseases and control
  • Neurogenesis and neuroplasticity mechanisms
  • Immune Response and Inflammation
  • Adenosine and Purinergic Signaling
  • Cytokine Signaling Pathways and Interactions
  • Tryptophan and brain disorders

Institute on Aging
2023-2024

University of Pennsylvania
2023-2024

HUN-REN Institute of Experimental Medicine
2018

Hungarian Academy of Sciences
2018

Leicester Royal Infirmary
1987-1991

Neurotropic herpesviruses can establish lifelong infection in humans and contribute to severe diseases including encephalitis neurodegeneration. However, the mechanisms through which brain's immune system recognizes controls viral infections propagating across synaptically linked neuronal circuits have remained unclear. Using a well-established model of alphaherpesvirus that reaches brain exclusively via retrograde transsynaptic spread from periphery, vivo two-photon imaging combined with...

10.1007/s00401-018-1885-0 article EN cc-by Acta Neuropathologica 2018-07-19

Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial Parkinson's disease (PD). These mutations elevate LRRK2 activity, making inhibitors an attractive therapeutic. activity has been consistently linked to specific cell signaling pathways, mostly related organelle trafficking and homeostasis, but its relationship PD pathogenesis more difficult define. LRRK2-PD patients present with loss dopaminergic neurons substantia nigra show variable development Lewy...

10.1186/s40035-024-00403-2 article EN cc-by Translational Neurodegeneration 2024-03-04

ABSTRACT Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial Parkinson’s disease (PD). These mutations elevate LRRK2 activity, making inhibitors an attractive therapeutic target. activity has been consistently linked to specific cell signaling pathways, mostly related organelle trafficking and homeostasis, but its relationship PD pathogenesis more difficult define. -PD patients present with loss dopaminergic neurons substantia nigra show variable...

10.1101/2023.10.06.561190 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2023-10-06
Coming Soon ...